We are live on ! Find out more
ZVRA icon

Zevra Therapeutics
ZVRA

70 hedge funds and large institutions have $98.1M invested in Zevra Therapeutics in 2021 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

346% more capital invested

Capital invested by funds: $22M → $98.1M (+$76.1M)

123% more call options, than puts

Call options by funds: $30.6M | Put options by funds: $13.7M

112% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 17

37% more funds holding

Funds holding: 51 → 70 (+19)

33% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 9

14.37% more ownership

Funds ownership: 8.26% → 22.63% (+14%)

Holders
70
Holders Change
+19
Holders Change %
+37.25%
% of All Funds
1.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
36
Increased
12
Reduced
9
Closed
17
Calls
$30.6M
Puts
$13.7M
Net Calls
+$16.9M
Net Calls Change
+$6.72M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$20.5M
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$7.77M
3
State Street
State Street
Massachusetts
+$5.31M
4
BFM
Boothbay Fund Management
New York
+$4.74M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$4.2M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$1.96M
2
Jane Street
Jane Street
New York
-$1.72M
3
Citadel Advisors
Citadel Advisors
Florida
-$1.39M
4
TRCT
Tower Research Capital (TRC)
New York
-$678K
5
HIIFS
Harel Insurance Investments & Financial Services
Israel
-$615K
Name Holding Trade Value Shares
Change 		Change in
Stake
RJFSA
26
Raymond James Financial Services Advisors
Florida
$281K -$3.49K -325 -1%
Morgan Stanley
27
Morgan Stanley
New York
$272K +$120K +11,141 +110%
MAM
28
Martingale Asset Management
Massachusetts
$262K +$220K +20,426 New
Deutsche Bank
29
Deutsche Bank
Germany
$244K +$204K +18,987 New
Marshall Wace
30
Marshall Wace
United Kingdom
$220K +$184K +17,153 New
Manulife (Manufacturers Life Insurance)
31
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$212K +$178K +16,550 New
SC
32
Sculptor Capital
New York
$176K – – –
WIA
33
World Investment Advisors
California
$171K -$5.37K -500 -4%
LPL Financial
34
LPL Financial
California
$170K +$142K +13,250 New
BAM
35
Blueshift Asset Management
New Jersey
$169K +$141K +13,153 New
Bank of America
36
Bank of America
North Carolina
$166K +$139K +12,950 New
CAN
37
Cetera Advisor Networks
California
$165K – – –
KWM
38
Kingsview Wealth Management
Oregon
$164K – – –
MIM
39
MetLife Investment Management
New Jersey
$149K +$125K +11,600 New
VOYA Investment Management
40
VOYA Investment Management
Georgia
$147K +$124K +11,493 New
CSS
41
Cubist Systematic Strategies
Connecticut
$146K +$123K +11,403 New
Invesco
42
Invesco
Georgia
$145K +$122K +11,330 New
JP Morgan Chase
43
JP Morgan Chase
New York
$141K +$118K +10,972 New
PCM
44
Pinz Capital Management
New York
$135K +$113K +10,500 New
V
45
Veritable
Delaware
$128K – – –
MLICM
46
Metropolitan Life Insurance Company (MetLife)
New York
$114K +$95.4K +8,881 New
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$98K +$20.2K +1,878 +33%
SO
48
STRS Ohio
Ohio
$84K +$70.9K +6,600 New
Wells Fargo
49
Wells Fargo
California
$73K +$25.7K +2,394 +72%
CG
50
Cutler Group
California
$55K -$93.7K -8,715 -67%
1
2
3 4

ZVRA Hedge Fund Activity: Q2 2021 in Review

70 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Zevra Therapeutics (ZVRA) for Q2 2021, worth a combined $98.1M — up 346% from $22M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new ZVRA positions and 17 closed out — a net gain of 19 holders — while 12 added to existing stakes and 9 trimmed.

The largest buyer was BlackRock, adding an estimated $20.5M. The largest seller was Millennium Management, exiting entirely with an estimated $1.96M sold.

  • 70 institutional investors held Zevra Therapeutics (ZVRA) as of Q2 2021, up from 51 in Q1 2021.
  • Funds reported $98.1M of Zevra Therapeutics stock for Q2 2021, up 346% quarter-over-quarter.
  • 36 funds opened new Zevra Therapeutics positions in Q2 2021 and 17 closed out, a net change of +19 holders.
  • The largest Zevra Therapeutics buyer in Q2 2021 was BlackRock, an estimated $20.5M added.
  • The largest Zevra Therapeutics seller in Q2 2021 was Millennium Management, an estimated $1.96M sold.

Based on aggregated 13F filings for Q2 2021.